Addressing Misunderstandings in Applying HBV Treatment Guidelines

Hear expert insights on why it is important to treat patients with HBV and cirrhosis and learn which treatment regimens are recommended and why.

Jean-Michel Pawlotsky, MD, PhD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: December 20, 2021 Expired: No longer available for credit

Here’s why it’s important to look for HDV coinfection in patients with HBV.

Francesco Negro, MD Released: July 7, 2021

The role of host factors in the monitoring and treatment of chronic hepatitis B is an area largely unexplored by the guidelines. Here’s my approach to assessing patients for treatment candidacy in the setting of other host factors.

Maria Buti, MD Released: August 26, 2021

This concise MedicalMinute presentation reviews the EASL recommendations for the individualizing treatment of HBV infection in persons at risk of renal or bone disease and pregnant women.

Francesco Negro, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: May 11, 2021 Expired: No longer available for credit

Hear expert insights on when to treat HBV: which factors to consider and how often to monitor them.

Maria Buti, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: September 7, 2021 Expired: No longer available for credit

In episode 6 of an ongoing series of sharing sessions between a physician and patient, Prof Tarik Asselah and his patient, who is living with chronic hepatitis B (CHB), discuss the importance and goals of treatment for hepatitis B and provide a message of hope for persons living with CHB.

Tarik Asselah, MD, PhD Released: February 18, 2022

In episode 4 of this ongoing series, listen to a conversation between Geoffrey M. Dusheiko, MD, FCP(SA), FRCP, and his patient Mark, who presented with hepatitis B after receiving immunomodulatory treatment for rheumatoid arthritis.

Geoffrey Dusheiko, FRCP, FRCP (Edin), FCP (SA) Released: July 26, 2021

Review key data and EASL guideline recommendations on individualizing treatment for patients with HBV, including patients with renal or bone disease and pregnant women.

Francesco Negro, MD Released: May 11, 2021